FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare's Board approved the audited consolidated financial results for FY2026 ended March 31, 2026. Revenue from operations grew 17.3% to Rs 912,784 lakhs from Rs 778,275 lakhs in the previous year. Net profit increased 31.5% to Rs 106,419 lakhs from Rs 80,938 lakhs year-on-year. EBITDA rose to Rs 213,564 lakhs from Rs 165,488 lakhs. The Board recommended a final dividend of Rs 1 per equity share (10% on face value of Rs 10 each) for FY2025-26, subject to shareholder approval at the AGM. The auditors issued an unmodified opinion on the financial statements.
The strong 31.5% profit growth demonstrates operational strength and may support the stock price. The modest Rs 1 per share dividend reflects a balanced approach between shareholder returns and capital preservation for growth investments. The ongoing SFIO investigation remains a background concern but did not affect the audit opinion.